Dr. Brad D Herman, D.C. Chiropractor - Independent Medical Examiner Medicare: Accepting Medicare Assignments Practice Location: 1519 B Main, Parsons, KS 67357 Phone: 620-421-3322 Fax: 620-423-0249 |
Parsons Chiropractic Llc Chiropractor - Independent Medical Examiner Medicare: Medicare Enrolled Practice Location: 1519 B Main, Parsons, KS 67357 Phone: 620-421-3322 Fax: 620-423-0249 |
Dr. Jeremy J Stover, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2328 Main St, Parsons, KS 67357 Phone: 620-717-4144 |
Lakin Chiropractic Clinic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2431 Main St, Parsons, KS 67357 Phone: 620-421-2790 |
Tullis Custom Chiropractic & Holistic Health Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 2431 Main St, Parsons, KS 67357 Phone: 620-717-4152 Fax: 620-717-4149 |
Dr. Audrey Elizabeth Tullis, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 3528 Main St, Parsons, KS 67357 Phone: 620-717-2734 |
Lakin Chiropractic Clinic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2431 Main St, Parsons, KS 67357 Phone: 620-421-2790 Fax: 620-421-2790 |
Dr. Thomas C Weaver, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1531 Main, Suite B, Parsons, KS 67357 Phone: 620-423-3370 Fax: 620-423-3370 |
News Archive
UnitedHealthcare, a UnitedHealth Group company, said its Military & Veterans Services business unit has been awarded the Department of Defense's TRICARE Managed Care Support contract to provide health care services for active duty and retired military service members and their families in the West Region.
ImmunoCellular Therapeutics, Ltd. today announced the establishment of an agreement with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma (GBM).
DGT Holdings Corp. announced today that it has completed the previously announced reverse stock split at a ratio of one-for-fifty and a forward stock split at a ratio of four-for-one. All shareholders owning fewer than fifty shares and all fractional shares remaining following the forward stock split have been cancelled and shareholders will receive a cash payment based on the ten day average closing price of the common stock prior to the splits.
Roche Diagnostics announced today that the U.S. Food and Drug Administration (FDA) granted Premarket Approval for its Elecsys Antibody to hepatitis C virus (anti-HCV) assay. The Elecsys Anti-HCV assay is an in-vitro diagnostic test for the qualitative detection of total antibodies to hepatitis C virus in human serum or plasma.
After years of working toward this goal, scientists at the OU Cancer Institute have found a way to isolate cancer stem cells in tumors so they can target the cells and kill them, keeping cancer from returning.
› Verified 9 days ago